Related by context. Frequent words. (Click for all words.) 67 Taiho Pharmaceutical Co. 66 Workers Struggles 65 Mitsubishi Tanabe Pharma 63 hepatitis B HBV 63 Receives Orphan Drug Designation 63 Initiates Phase II 63 Argatroban 62 Acquires Exclusive 61 Kuvan R 61 apaziquone 60 Rotarix R 60 Kyowa Hakko Kogyo Co. 60 Cilag GmbH International 60 Janssen Pharmaceutica NV 60 Orphan Drug designation 59 Teijin Pharma 59 Elan Pharma 59 Titanium Dioxide Products 59 brands include Weedol 58 sublicensed 58 Eligard R 58 developing biomedical countermeasures 58 NV Organon 58 intravenous formulations 58 Cetrorelix 58 post herpetic neuralgia PHN 58 Medarex logo 58 CTS manufactures 58 novel antibody therapeutics 58 EMRISE serves 58 Meda AB 57 Completes Enrollment 57 Commercialization Agreement 57 Announces Initiation 57 @ nypost.com 57 Inc Therapeutic Competitors 57 AnGes 57 R sorafenib tablets 57 Application MAA 57 Nippon Kayaku 57 Patent Covering 57 CPL Biologicals 57 Distribution Agreements 57 ZALBIN 57 oncology indications 57 joint venture fab SSMC 57 Dynepo 57 Exploit collaboration 57 Shareholders Approve Acquisition 56 Chugai Pharmaceutical Japan 56 Kyowa Hakko Kirin 56 Expands Distribution 56 Cambridge MA Pegasystems 56 Files Shelf Registration Statement 56 Orphan Drug status 56 Nimotuzumab 56 Copegus R 56 Commercialize 56 Meets Primary Endpoint 56 topical anti infective 56 Allovectin 7 R 56 inflammatory autoimmune diseases 56 Loramyc R 56 Takeda Kyowa Hakko Kirin 56 Advancing Drugs 56 Nipent 56 #-# Abstract Full Text 56 Completes Tender Offer 56 refractory chronic lymphocytic 56 eprodisate KIACTA TM 56 Vitaros ® 56 Announces FDA Clearance 56 Epson disclaims 56 GVAX cancer 56 MuGard TM 55 forodesine HCl 55 Orphan Drug Status 55 Shigamabs ® 55 Uracyst R 55 phenylketonuria PKU developed 55 Vaccinex 55 Onalta 55 Nobilon 55 gets USFDA nod 55 Visudyne R 55 Multiferon R 55 Exclusive Distributor 55 neovascular age 55 TranSwitch indebtedness 55 Mundipharma 55 Recombinant Human 55 Æterna Zentaris 55 Kyowa Hakko Kogyo 55 Uracyst ® 55 tetrabenazine 55 hepatitis C HCV 55 Finalizes Acquisition 55 Shigamabs R 55 oropharyngeal candidiasis 55 diabetic peripheral neuropathic pain 55 CDP#